Safeguard Scientifics (NYSE:SFE) was upgraded by ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued on Thursday, ValuEngine reports.
Separately, Zacks Investment Research raised Safeguard Scientifics from a “hold” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research report on Tuesday, May 7th.
Shares of NYSE:SFE opened at $11.28 on Thursday. The firm has a market capitalization of $229.22 million, a P/E ratio of -14.84 and a beta of 0.87. Safeguard Scientifics has a 1 year low of $7.98 and a 1 year high of $12.91. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.03. The business’s 50 day moving average is $11.81.
Several hedge funds have recently modified their holdings of SFE. Zeke Capital Advisors LLC acquired a new stake in shares of Safeguard Scientifics in the 1st quarter valued at $2,212,000. Almitas Capital LLC boosted its holdings in shares of Safeguard Scientifics by 63.5% in the 1st quarter. Almitas Capital LLC now owns 402,998 shares of the asset manager’s stock valued at $4,373,000 after purchasing an additional 156,580 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Safeguard Scientifics by 26.6% in the 2nd quarter. Janus Henderson Group PLC now owns 600,355 shares of the asset manager’s stock valued at $7,237,000 after purchasing an additional 126,008 shares in the last quarter. Strs Ohio acquired a new stake in shares of Safeguard Scientifics in the 2nd quarter valued at $582,000. Finally, Yakira Capital Management Inc. boosted its holdings in shares of Safeguard Scientifics by 2.7% in the 1st quarter. Yakira Capital Management Inc. now owns 818,289 shares of the asset manager’s stock valued at $8,878,000 after purchasing an additional 21,600 shares in the last quarter. 68.50% of the stock is currently owned by hedge funds and other institutional investors.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Story: What is systematic risk?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.